tiprankstipranks
Trending News
More News >
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Ratios

Compare
10 Followers

Hansa Biopharma AB Ratios

SE:HNSA's free cash flow for Q3 2025 was kr0.35. For the 2025 fiscal year, SE:HNSA's free cash flow was decreased by kr and operating cash flow was kr-4.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.11 2.66 6.06 5.50 12.20
Quick Ratio
1.10 2.66 6.06 5.50 12.20
Cash Ratio
0.60 2.28 5.65 3.80 9.98
Solvency Ratio
-0.49 -0.69 -0.55 -2.11 -2.15
Operating Cash Flow Ratio
-1.33 -2.35 -1.90 -2.81 -2.54
Short-Term Operating Cash Flow Coverage
-3.78 0.00 12.25 19.28 16.68
Net Current Asset Value
kr -837.71Mkr -330.77Mkr 520.21Mkr 687.11Mkr 1.20B
Leverage Ratios
Debt-to-Assets Ratio
1.25 0.85 0.47 0.03 <0.01
Debt-to-Equity Ratio
-1.65 -5.16 1.31 0.05 <0.01
Debt-to-Capital Ratio
2.54 1.24 0.57 0.04 <0.01
Long-Term Debt-to-Capital Ratio
3.62 1.25 0.56 0.00 0.00
Financial Leverage Ratio
-1.32 -6.06 2.80 1.34 1.15
Debt Service Coverage Ratio
-1.59 -6.78 -211.02 22.21 24.09
Interest Coverage Ratio
-3.44 -7.47 -13.19 -777.49 -1.65K
Debt to Market Cap
0.32 0.61 0.33 >-0.01 >-0.01
Interest Debt Per Share
12.75 18.51 18.58 0.81 0.13
Net Debt to EBITDA
-1.40 -0.19 1.27 1.14 2.75
Profitability Margins
Gross Profit Margin
59.47%52.91%75.10%54.47%83.65%
EBIT Margin
-268.25%-540.88%-366.49%-1615.90%-6897.93%
EBITDA Margin
-268.25%-532.88%-358.69%-1590.50%-6774.09%
Operating Profit Margin
-302.17%-588.02%-372.83%-1592.72%-6970.76%
Pretax Profit Margin
-356.04%-619.57%-394.74%-1617.95%-6902.15%
Net Profit Margin
-358.67%-620.25%-395.49%-1618.40%-6901.49%
Continuous Operations Profit Margin
-358.67%-620.25%-395.49%-1618.40%-6901.49%
Net Income Per EBT
100.74%100.11%100.19%100.03%99.99%
EBT Per EBIT
117.83%105.37%105.88%101.58%99.02%
Return on Assets (ROA)
-86.44%-81.70%-36.22%-54.13%-29.34%
Return on Equity (ROE)
115.70%495.44%-101.36%-72.37%-33.88%
Return on Capital Employed (ROCE)
-167.91%-113.12%-40.50%-64.11%-32.20%
Return on Invested Capital (ROIC)
-115.77%-112.04%-41.56%-65.54%-32.51%
Return on Tangible Assets
-134.68%-94.28%-37.25%-55.72%-29.99%
Earnings Yield
-22.40%-60.42%-27.64%-13.88%-4.15%
Efficiency Ratios
Receivables Turnover
0.86 1.72 2.38 3.49 55.44
Payables Turnover
1.14 0.73 0.62 0.29 0.04
Inventory Turnover
20.51 41.73 39.54 63.74 10.17
Fixed Asset Turnover
15.49 4.95 4.31 0.74 0.63
Asset Turnover
0.24 0.13 0.09 0.03 <0.01
Working Capital Turnover Ratio
1.77 0.14 0.15 0.03 <0.01
Cash Conversion Cycle
123.25 -281.58 -429.87 -1.15K -9.72K
Days of Sales Outstanding
426.15 212.38 153.56 104.64 6.58
Days of Inventory Outstanding
17.79 8.75 9.23 5.73 35.88
Days of Payables Outstanding
320.69 502.71 592.66 1.26K 9.76K
Operating Cycle
443.94 221.13 162.79 110.36 42.46
Cash Flow Ratios
Operating Cash Flow Per Share
-6.61 -14.38 -11.19 -10.82 -6.88
Free Cash Flow Per Share
-6.62 -14.39 -11.26 -10.87 -6.89
CapEx Per Share
<0.01 <0.01 0.07 0.05 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-891.86 -2.66K -150.93 -200.57 -987.33
Capital Expenditure Coverage Ratio
-891.86 -2.66K -150.93 -200.57 -987.33
Operating Cash Flow Coverage Ratio
-0.61 -0.87 -0.64 -13.60 -57.54
Operating Cash Flow to Sales Ratio
-3.14 -5.64 -3.25 -14.20 -47.60
Free Cash Flow Yield
-19.61%-54.92%-22.89%-12.24%-2.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.46 -1.66 -3.62 -7.20 -24.09
Price-to-Sales (P/S) Ratio
16.01 10.27 14.31 116.57 1.66K
Price-to-Book (P/B) Ratio
-5.10 -8.20 3.67 5.21 8.16
Price-to-Free Cash Flow (P/FCF) Ratio
-5.10 -1.82 -4.37 -8.17 -34.89
Price-to-Operating Cash Flow Ratio
-5.11 -1.82 -4.40 -8.21 -34.93
Price-to-Earnings Growth (PEG) Ratio
1.76 -0.10 -0.35 -0.31 -2.21
Price-to-Fair Value
-5.10 -8.20 3.67 5.21 8.16
Enterprise Value Multiple
-7.37 -2.11 -2.72 -6.19 -21.80
Enterprise Value
3.53B 1.51B 1.51B 3.33B 9.01B
EV to EBITDA
-7.37 -2.11 -2.72 -6.19 -21.80
EV to Sales
19.77 11.27 9.75 98.39 1.48K
EV to Free Cash Flow
-6.30 -2.00 -2.98 -6.89 -30.99
EV to Operating Cash Flow
-6.31 -2.00 -3.00 -6.93 -31.02
Tangible Book Value Per Share
-9.75 -5.78 12.38 16.39 28.71
Shareholders’ Equity Per Share
-6.62 -3.20 13.42 17.03 29.45
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 <0.01
Revenue Per Share
2.11 2.55 3.44 0.76 0.14
Net Income Per Share
-7.56 -15.83 -13.60 -12.33 -9.98
Tax Burden
1.01 1.00 1.00 1.00 1.00
Interest Burden
1.33 1.15 1.08 1.00 1.00
Research & Development to Revenue
1.86 3.07 2.24 6.81 37.26
SG&A to Revenue
1.43 3.36 2.19 9.66 33.29
Stock-Based Compensation to Revenue
0.00 0.00 0.38 1.67 7.11
Income Quality
0.87 0.91 0.82 0.88 0.69
Currency in SEK